{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:43:12Z","timestamp":1790383392934,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Lupus nephritis (LN) is one of the most severe organ manifestations of systemic lupus erythematosus (SLE). Chronic kidney disease (CKD) and its progression into end-stage renal disease (ESRD) are serious complications in LN and the main cause of death in SLE. We aimed to investigate the prognostic factors of the progression of CKD and the development of ESRD in SLE patients. Methods: In our retrospective cohort study, we assessed the clinical and laboratory data of 127 patients who were diagnosed with LN between 1990 and 2022 and received regular follow-up care at our autoimmune centre. We compared class IV (diffuse) LN patients with non-class IV LN patients and assessed the differences in clinical and laboratory data of the patients, subdivided into complete, partial, and non-responders to therapy. Results: The prevalence of class IV LN is significantly higher in patients with CKD stage 3\u20135. Age above 42, class IV LN, Coombs positivity, and high chronicity index are prognostic factors for the development of CKD stage 3\u20135. On the other hand, anti-RNP and anti-SS-B antibody positivity and a high chronicity index are prognostic factors for the development of ESRD. The chronicity index, as well as the SLICC\/ACR Damage Index (SDI) score, was significantly higher in non-responders compared to patients with complete remission. Conclusions: Based on our results, the progression of CKD into stage 3\u20135 or the development of ESRD should be expected at a chronicity index above 3.5 points. An early diagnosis, as well as aggressive, timely, and adequate treatment, is fundamental to prevent unfavourable outcomes of LN.<\/jats:p>","DOI":"10.3390\/jcm14030665","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:47:42Z","timestamp":1737438462000},"page":"665","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic Factors of the Progression of Chronic Kidney Disease and the Development of End-Stage Renal Disease in Patients with Lupus Nephritis: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Bianka","family":"Perge","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-190X","authenticated-orcid":false,"given":"G\u00e1bor","family":"Papp","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"B\u00f3i","sequence":"additional","affiliation":[{"name":"Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, H-4028 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Mark\u00f3th","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Bidiga","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"Farmasi","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-2645","authenticated-orcid":false,"given":"J\u00f3zsef","family":"Balla","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcnde","family":"Tarr","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"ref_1","first-page":"330","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000368585","article-title":"Rituximab in systemic lupus erythematosus and lupus nephritis","volume":"128","author":"Beckwith","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: A pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","article-title":"Lupus nephritis-related chronic kidney disease","volume":"20","author":"Lichtnekert","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: Clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0961203308100481","article-title":"European consensus statement on the terminology used in the management of lupus glomerulonephritis","volume":"18","author":"Gordon","year":"2009","journal-title":"Lupus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","unstructured":"Churg, J., and Sobin, L. (1982). Renal Disease: Classification and Atlas of Glomerular Disease, Igaku-Shoin Ltd."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"ref_12","first-page":"31","article-title":"Systemic lupus erythematosus: Reducing life-threatening progression","volume":"19","author":"Inderjeeth","year":"2018","journal-title":"Med. Today"},{"key":"ref_13","first-page":"17","article-title":"Lupus nephritis in 2017: An update","volume":"9","author":"Lau","year":"2017","journal-title":"ASN Kidney News"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/ard.62.9.799","article-title":"Treatment of severe proliferative lupus nephritis: The current state","volume":"62","author":"Mok","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: Consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the management of Lupus Nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/mr\/roac007","article-title":"Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan","volume":"33","author":"Tanaka","year":"2023","journal-title":"Mod. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/art.41508","article-title":"Urinary Biomarkers in Lupus Nephritis: Are We There Yet?","volume":"73","author":"Mok","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Palazzo, L., Lindblom, J., Mohan, C., and Parodis, I. (2022). Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195759"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of End-Stage Renal Disease in Patients with Lupus Nephritis, 1971\u20132015: A Systematic Review and Bayesian Meta-Analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: Results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MD.0b013e3181f27e8f","article-title":"Outcomes in biopsy-proven lupus nephritis: Evaluation of 190 white patients from a single center","volume":"89","author":"Siso","year":"2010","journal-title":"Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"International Society of Nephrology (2013). Kidney Disease: Improving Global Outcomes (KDIGO). Chapter 1: Definition and classification of CKD. Kidney Int. Suppl., 3, 19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0961203314563817","article-title":"Similarities and differences between pediatric and adult patients with systemic lupus erythematosus","volume":"24","author":"Tarr","year":"2015","journal-title":"Lupus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5606\/ArchRheumatol.2017.6127","article-title":"A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis","volume":"33","author":"Wang","year":"2017","journal-title":"Arch. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: Clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0961203319890681","article-title":"Initial renal histology and early response predict outcomes of Brazilian lupus nephritis patients","volume":"29","author":"Vajgel","year":"2020","journal-title":"Lupus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1177\/0961203317716320","article-title":"Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: A university hospital experience","volume":"26","author":"Momtaz","year":"2017","journal-title":"Lupus"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2891","DOI":"10.1097\/MD.0000000000002891","article-title":"Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)","volume":"95","author":"Freire","year":"2016","journal-title":"Medicine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/acr.22685","article-title":"Incidence of endstage renal disease among newly diagnosed systemic lupus erythematosus patients: The Georgia Lupus Registry","volume":"68","author":"Plantinga","year":"2016","journal-title":"Arthritis Care Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/0961203317694257","article-title":"Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis","volume":"26","author":"Park","year":"2017","journal-title":"Lupus"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203313492576","article-title":"Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years","volume":"22","author":"Moroni","year":"2013","journal-title":"Lupus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11255-014-0903-y","article-title":"Clinicopathological and outcome analysis of adult lupus nephritis patients in China","volume":"47","author":"Tang","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group","volume":"35","author":"Korbet","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4078\/jrd.22.0006","article-title":"Predictive Factors for Renal Response in Lupus Nephritis: A Single-center Prospective Cohort Study","volume":"29","author":"Park","year":"2022","journal-title":"J. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/09612033221106305","article-title":"Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience","volume":"31","author":"Duran","year":"2022","journal-title":"Lupus"},{"key":"ref_45","first-page":"211","article-title":"Clinicopathological relationship in Colombian patients with lupusnephritis","volume":"24","author":"Ospina","year":"2017","journal-title":"Rev. Colum. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/665\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:32:39Z","timestamp":1759919559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14030665"],"URL":"https:\/\/doi.org\/10.3390\/jcm14030665","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}